These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35204197)

  • 21. Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.
    Sathyasaikumar KV; Stachowski EK; Amori L; Guidetti P; Muchowski PJ; Schwarcz R
    J Neurochem; 2010 Jun; 113(6):1416-25. PubMed ID: 20236387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Study Between Kynurenine 3-Monooxygenase (KMO) Gene and Parkinson's Disease Patients.
    Babu HWS; Elangovan A; Iyer M; Kirola L; Muthusamy S; Jeeth P; Muthukumar S; Vanlalpeka H; Gopalakrishnan AV; Kadhirvel S; Kumar NS; Vellingiri B
    Mol Neurobiol; 2024 Jul; 61(7):3867-3881. PubMed ID: 38040995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.
    Hughes TD; Güner OF; Iradukunda EC; Phillips RS; Bowen JP
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.
    Fiedorowicz M; Choragiewicz T; Thaler S; Schuettauf F; Nowakowska D; Wojtunik K; Reibaldi M; Avitabile T; Kocki T; Turski WA; Kaminska A; Grieb P; Zrenner E; Rejdak R; Toro MD
    Front Physiol; 2019; 10():1254. PubMed ID: 31632294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.
    Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R
    Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane.
    Swaih AM; Breda C; Sathyasaikumar KV; Allcock N; Collier MEW; Mason RP; Feasby A; Herrera F; Outeiro TF; Schwarcz R; Repici M; Giorgini F
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
    Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
    Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.
    Notarangelo FM; Wang XD; Horning KJ; Schwarcz R
    J Neurochem; 2016 Feb; 136(4):804-814. PubMed ID: 26661897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression.
    Chen Y; Zhang J; Yang Y; Xiang K; Li H; Sun D; Chen L
    J Cell Physiol; 2022 Dec; 237(12):4339-4355. PubMed ID: 36088660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
    Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
    Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
    Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
    Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
    Holtze M; Saetre P; Engberg G; Schwieler L; Werge T; Andreassen OA; Hall H; Terenius L; Agartz I; Jönsson EG; Schalling M; Erhardt S
    J Psychiatry Neurosci; 2012 Jan; 37(1):53-7. PubMed ID: 21693093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons.
    O'Farrell K; Fagan E; Connor TJ; Harkin A
    Eur J Pharmacol; 2017 Sep; 810():163-173. PubMed ID: 28688912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of N-(6-(5-fluoro-2-(piperidin-1-yl)phenyl)pyridazin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)methanesulfonamide as a brain-permeable and metabolically stable kynurenine monooxygenase inhibitor.
    Tsuboi K; Kimura H; Nakatsuji Y; Kassai M; Deai Y; Isobe Y
    Bioorg Med Chem Lett; 2021 Jul; 44():128115. PubMed ID: 34015507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Carpenedo R; Meli E; Peruginelli F; Pellegrini-Giampietro DE; Moroni F
    J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
    Notarangelo FM; Beggiato S; Schwarcz R
    Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kynurenine Pathway as a New Target of Cognitive Impairment Induced by Lead Toxicity During the Lactation.
    Ramirez Ortega D; Ovalle Rodríguez P; Pineda B; González Esquivel DF; Ramos Chávez LA; Vázquez Cervantes GI; Roldán Roldán G; Pérez de la Cruz G; Díaz Ruiz A; Méndez Armenta M; Marcial Quino J; Gómez Manzo S; Ríos C; Pérez de la Cruz V
    Sci Rep; 2020 Feb; 10(1):3184. PubMed ID: 32081969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.